What medicines does Genentech make?
Our Medicines & Products
- Medicines.
- Actemra® (TOCILIZUMAB [authorized for Emergency Use])
- Actemra® (tocilizumab)
- Activase® (alteplase)
- Alecensa® (alectinib)
- Avastin® (bevacizumab)
- Boniva Tablets® (ibandronate sodium)
- Cathflo Activase® (alteplase)
Is Genentech a real company?
Genentech Inc. operates as a biotechnology company. The Company develops, manufactures, and commercializes medicines to treat patients with serious and life-threatening medical conditions.
How much is Genentech worth?
The deal values Genentech as a whole at $100.1 billion when including the portion of the company already owned by Roche. That nearly matches the $109.1 billion combined total for Merck's and Pfizer's acquisitions.
What drugs does Celgene make?
Celgene Corporation is a pharmaceutical company that makes cancer and immunology drugs. Its major product is Revlimid (lenalidomide), which is used in the treatment of multiple myeloma, and also in certain anemias.
Does Celgene still exist?
Celgene common stock ceased trading as of the close of trading today. On November 21, 2019, newly issued Bristol-Myers Squibb shares and CVRs will commence trading on the New York Stock Exchange, with the CVRs trading under the symbol “BMYRT.”
Is Bristol Myers still in business?
BMS is one of the world's largest pharmaceutical companies, and is consistently ranked on the Fortune 500 list of the largest U.S. corporations. As of September 2020, it had total revenue of $39.3 billion.
...
Bristol Myers Squibb.
| A Bristol Myers Squibb R&D facility in Lawrence, New Jersey |
| Website |
BMS.com |
15 more rows
What drugs does Bristol Myers make?
Our medicines
- ABECMA® (idecabtagene vicleucel) ...
- ABRAXANE® (paclitaxel protein-bound particles for injectable suspension) (albumin-bound) ...
- AZACTAM® (aztreonam for injection, USP) ...
- BREYANZI® (lisocabtagene maraleucel) ...
- BARACLUDE® (entecavir) ...
- DROXIA® (hydroxyurea) ...
- ELIQUIS® (apixaban) ...
- EMPLICITI® (elotuzumab)
Where is Celgene manufactured?
Did BMY buy Celgene?
By erasing one of the industry's most active partners, the $74 billion deal promises to shake up biotech for years to come. Love it or hate it, Bristol-Myers Squibb's purchase of Celgene set the tone for 2019, and promises to shake up the life sciences ecosystem for years to come.
How do I contact Bristol Myers Squibb?
Contact Us
- Customer and Community Relations. 1-800-332-2056. (toll free U.S. only)
- Report Side Effects or Product Quality Complaints. 1-800-721-5072. (toll free U.S. only)
- Medical Information Contact Center. 1-800-321-1335. (toll free U.S. only) Mon - Fri 8am - 8pm ET.
What BMS known for?
The company is known for biological and pharmaceutical research, producing the antipsychotic Abilify (which it helps market) and its blood thinners Plavix and Eliquis, as well as cancer drug Opdivo.